skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

25 Total results for product and free and sample content found

Citeline, Pharmaprojects

Navigate the landscape in our Pharma R&D Annual Review 2022

14 Apr 2022

Navigate the landscape in our Pharma R&D Annual Review 2022

Our world was disrupted at warp speed during 2020. Are you ready to gain a deeper understanding of the year that changed our perceptions of possible? 

Topic clinical-trials diseases drug-review

Top 10 Best-Selling Drugs of 2019

By Stephanie Yip 23 Oct 2020

In 2019, the 10 most lucrative medicines generated combined global sales of $92.5B. Scrip provides insight into these top sellers and the companies behind them, as well US dynamics, global sales forecasts and lifecycle data, with complementary market analysis from Datamonitor Healthcare on diseases targeted, indications, and more.

Topic drug-review diseases

Rare Congenital and Genetic Diseases Strategy Solutions

09 Oct 2020

Rare Congenital and Genetic Diseases Strategy Solutions

Gain Clarity of Sight into What Comes Next with Citeline According to Informa’s Pharmaprojects, less than 3% of all rare congenital and genetic diseases have an approved therapy. Opportunities abound ­if you know the risks. Make better strategic and planning decisions with Intelligence services that give you a clear line of sight, helping you maximize clinical and commercial opportunities, navigate uncertainties, and ensure more successful outcomes. 

Topic diseases

NASH Disease Coverage Extract

16 Aug 2019

NASH Disease Coverage Extract

Datamonitor Healthcare recently surveyed 60 gastroenterologists in the US and five major EU markets after the approval of the first disease-specific therapies for the treatment of non-alcoholic steatohepatitis (NASH). The market for these treatments will exceed $21bn in 2027.   

Topic drug-development-landscape diseases

Could The Gut Cure Brain Disease?

By Melanie Senior 08 Aug 2019

Could The Gut Cure Brain Disease?

Scientists now understand that there are multiple, bi-directional links between gut and brain. They are using this knowledge to develop new treatments for some of the most challenging chronic conditions, including Alzheimer’s disease, Parkinson’s disease and obesity.

Topic diseases

Finance Watch: Alternative Funding Sources Crucial Even Amidst A Biopharma VC Boom

02 Jul 2019

Finance Watch: Alternative Funding Sources Crucial Even Amidst A Biopharma VC Boom

Private Company Edition: Investments by CIRM, the GHIT fund and the European Investment Bank back early-stage science and treatments for neglected diseases. Also, Versant Ventures raises $700m in two funds. In VC deals, Akero raised $70m, Impel NeuroPharma brought in $67.5m.

Topic diseases

World AIDS Day 2018 GlaxoSmithKline report

11 Jun 2019

World AIDS Day 2018 GlaxoSmithKline report

PharmaVitae explores GlaxoSmithKline’s prescription pharmaceutical performance and outlook over 2017–27. PharmaVitae analyses include quarterly earnings coverage and provide timely updates to company product forecasts. The full company profile encompasses analysis on corporate strategy, portfolio analysis, pipeline potential, and financial performance.

Topic diseases drug-development-landscape drug-review

Pharma R&D Annual Review 2019

30 May 2019

 Pharma R&D Annual Review 2019

Pharma R&D Annual Review 2019 is based on the stats and data from from Pharmaprojects, part of Informa’s Citeline family of intelligence solutions. Authored for the 27th time by Ian Lloyd, Senior Director, Pharmaprojects.

Topic clinical-trials diseases research drug-approval drug-review

Lysosomal Storage Disorders (LSDs): Epidemiology & Treatment Overview

By Niharika Dandamudi 15 Apr 2019

Lysosomal Storage Disorders (LSDs): Epidemiology & Treatment Overview

Lysosomal storage diseases (LSDs) are a rare distinct group of disorders with complex diagnosis and limited epidemiology data, such as Pompe disease. In recognition of International Pompe Day, marked on April 15, we created the below infographic to provide some insight into epidemiology and present an overview of current treatment options.

Topic diseases

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: